Journals / Turkish Journal of Gastroenterology / 2017 / Cilt: 28 - Sayı: 1

Treatment of reflux disease during pregnancy and lactation

Pages
53–56
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In cases with GERD during the lactation period, drugs having minimum systemic absorption, such as sucralfate and alginic acid, are preferable but there is no data

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Gastroesophageal reflux disease (GERD) is frequently seen during pregnancy.
📊
Key Findings & Data:In particular, ranitidine -a histamine-2 receptor blocker- is preferred.
💡
Conclusion & Impact:In cases with GERD during the lactation period, drugs having minimum systemic absorption, such as sucralfate and alginic acid, are preferable but there is no data
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Gastroesophageal reflux disease (GERD) is frequently seen during pregnancy. In the medical treatment of pregnant women with GERD, alginic acid and sucralfate can be used. Calcium- and magnesium-based antacids can also be used, particularly for patients with preeclampsia. In particular, ranitidine -a histamine-2 receptor blocker- is preferred. In the case of non-responsiveness to the abovementioned treatments, proton pump inhibitors (PPIs), except omeprazole, can be given considering the benefit-harm ratio for the mother and fetus after the first trimester. In cases with GERD during the lactation period, drugs having minimum systemic absorption, such as sucralfate and alginic acid, are preferable but there is no data

🔖

Cite This Article

DAĞLI, Ü., KALKAN, İ. H. (2017). Treatment of reflux disease during pregnancy and lactation. Turkish Journal of Gastroenterology, Cilt: 28 - Sayı: 1, 53–56. https://ajindex.com/articles/410732

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ho KY, Kang JY, Viegas OA. Symptomatic gastro-oesophageal reflux in pregnancy: a prospective study among Singaporean women. J Gastroenterol Hepatol 1998
  2. [CrossRef] 2. Ramu B, Mohan P, Rajasekaran MS, Jayanthi V. Prevalence and risk factors for gastroesophageal reflux in pregnancy. Indian J Gastroenterol 2011
  3. [CrossRef] 3. Rey E, Rodriguez-Artalejo F, Herraiz MA, et al. Gastroesophageal reflux symptoms during and after pregnancy: a longitudinal study. Am J Gastroenterol 2007
  4. [CrossRef] 4. Richter JE. Gastroesophageal reflux disease during pregnancy. Gastroenterol Clin North Am 2003
  5. [CrossRef] 5. Richter JE. Review article: the management of heartburn in pregnancy. Aliment Pharmacol Ther 2005
  6. [CrossRef] 6. Witten FP, King TM, Blake O. The effects of chronic gastrointestinal medications on the fetus and neonate. Obstet Gynecol 1981
  7. 58(Suppl 5): 79-84. 7. Broussard CN, Richter JE. Treating gastro-oesophageal reflux disease during pregnancy and lactation: what are the safest therapy options? Drug Saf 1998
  8. [CrossRef] 8. Tytgat GN, Heading RC, Müller-Lissner S, et al. Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting. Aliment Pharmacol Ther 2003
  9. [CrossRef] 9. Briggs GG, Freeman RY, Yaffe SJ. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Baltimore, USA: William and Wilkins, 2002. 10. Strugala V, Bassin J, Swales VS, Lindow SW, Dettmar PW, Thomas EC. Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy. ISRN Obstet Gynecol 2012
  10. 481870. [CrossRef] 11. Ranchet G, Gangemi O, Petrone M. Sucralfate in the treatment of gravid pyrosis. G Ital Obstet Ginecol 1990
  11. Berkovitch M, Elbirt D, Addis A, Schuler-Faccini L, Ornoy A. Fetal effects of metoclopramide therapy for nausea and vomiting of pregnancy. N Engl J Med 2000
  12. [CrossRef] 13. Sørensen HT, Nielsen GL, Christensen K, Tage-Jensen U, Ekbom A, Baron J. Birth outcome following maternal use of metoclopramide. The Euromap study group. Br J Clin Pharmacol 2000
  13. [CrossRef] 14. Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Levy A. The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med 2009
  14. [CrossRef] 15. Niebyl JR. Teratology a